Literature DB >> 33440102

Outcome and status of postcardiac arrest care in Korea: results from the Korean Hypothermia Network prospective registry.

Soo Hyun Kim1, Kyu Nam Park2, Chun Song Youn2, Minjung Kathy Chae3, Won Young Kim4, Byung Kook Lee5, Dong Hoon Lee6, Tae Chang Jang7, Jae Hoon Lee8, Yoon Hee Choi9, Je Sung You10, In Soo Cho11, Su Jin Kim12, Jong-Seok Lee13, Yong Hwan Kim14, Min Seob Sim15, Jonghwan Shin16, Yoo Seok Park17, Young Hwan Lee18, HyungJun Moon19, Won Jung Jeong20, Joo Suk Oh21, Seung Pill Choi1,22, Kyoung-Chul Cha23.   

Abstract

OBJECTIVE: High-quality intensive care, including targeted temperature management (TTM) for patients with postcardiac arrest syndrome, is a key element for improving outcomes after out-of-hospital cardiac arrest (OHCA). We aimed to assess the status of postcardiac arrest syndrome care, including TTM and 6-month survival with neurologically favorable outcomes, after adult OHCA patients were treated with TTM, using data from the Korean Hypothermia Network prospective registry.
METHODS: We used the Korean Hypothermia Network prospective registry, a web-based multicenter registry that includes data from 22 participating hospitals throughout the Republic of Korea. Adult comatose OHCA survivors treated with TTM between October 2015 and December 2018 were included. The primary outcome was neurological outcome at 6 months.
RESULTS: Of the 1,354 registered OHCA survivors treated with TTM, 550 (40.6%) survived 6 months, and 413 (30.5%) had good neurological outcomes. We identified 839 (62.0%) patients with preClinsumed cardiac etiology. A total of 937 (69.2%) collapses were witnessed, shockable rhythms were demonstrated in 482 (35.6%) patients, and 421 (31.1%) patients arrived at the emergency department with prehospital return of spontaneous circulation. The most common target temperature was 33°C, and the most common target duration was 24 hours.
CONCLUSION: The survival and good neurologic outcome rates of this prospective registry show great improvements compared with those of an earlier registry. While the optimal target temperature and duration are still unknown, the most common target temperature was 33°C, and the most common target duration was 24 hours.

Entities:  

Keywords:  Critical care outcomes; Hypothermia, induced; Out-of-hospital cardiac arrest; Registries

Year:  2020        PMID: 33440102     DOI: 10.15441/ceem.20.035

Source DB:  PubMed          Journal:  Clin Exp Emerg Med        ISSN: 2383-4625


  4 in total

1.  External validation of the 2020 ERC/ESICM prognostication strategy algorithm after cardiac arrest.

Authors:  Chun Song Youn; Kyu Nam Park; Soo Hyun Kim; Byung Kook Lee; Tobias Cronberg; Sang Hoon Oh; Kyung Woon Jeung; In Soo Cho; Seung Pill Choi
Journal:  Crit Care       Date:  2022-04-11       Impact factor: 9.097

2.  External validation of cardiac arrest-specific prognostication scores developed for early prognosis estimation after out-of-hospital cardiac arrest in a Korean multicenter cohort.

Authors:  Wan Young Heo; Yong Hun Jung; Hyoung Youn Lee; Kyung Woon Jeung; Byung Kook Lee; Chun Song Youn; Seung Pill Choi; Kyu Nam Park; Yong Il Min
Journal:  PLoS One       Date:  2022-04-01       Impact factor: 3.240

3.  The association of different target temperatures in targeted temperature management with neurological outcome after out-of-hospital cardiac arrest based on a prospective multicenter observational study in Korea (the KORHN-PRO registry): IPTW analysis.

Authors:  Hyo Joon Kim; Chun Song Youn; Kyu Nam Park; Young-Min Kim; Byung Kook Lee; Kyung Woon Jeung; Won Young Kim; Seung Pill Choi; Soo Hyun Kim
Journal:  PLoS One       Date:  2022-07-22       Impact factor: 3.752

4.  Effects of Sodium Nitroprusside Administered Via a Subdural Intracranial Catheter on the Microcirculation, Oxygenation, and Electrocortical Activity of the Cerebral Cortex in a Pig Cardiac Arrest Model.

Authors:  Hyoung Youn Lee; Yong Hun Jung; Najmiddin Mamadjonov; Kyung Woon Jeung; Min Chul Kim; Kyung Seob Lim; Chang-Yeop Jeon; Youngjeon Lee; Hyung Joong Kim
Journal:  J Am Heart Assoc       Date:  2022-05-27       Impact factor: 6.106

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.